Mar­ket­ingRx roundup: Phar­ma in­dus­try rep drops in Gallup poll; Pfiz­er web­site re­veals not-yet-ap­proved drug name

Has the Covid-19 pan­dem­ic good­will ha­lo for the phar­ma in­dus­try worn off? The lat­est US Gallup an­nu­al busi­ness sec­tor poll shows it is slip­ping with a 7% drop in pos­i­tive pub­lic per­cep­tion. On­ly 18% of Amer­i­cans sur­veyed this year rat­ed their view of phar­ma as “very pos­i­tive” or “some­what pos­i­tive,” down from 25% in 2022.

That puts the in­dus­try in last place among the 25 in­dus­tries Gallup asked about. Even the fed­er­al gov­ern­ment ranked high­er at 21%, while oil and gas got 24%, and the le­gal field and ad­ver­tis­ing and pub­lic re­la­tions both cap­tured 25% of the pop­u­la­tion’s pos­i­tive per­cep­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER